Relationship between cerebrospinal and peripheral S100B levels after focal cerebral ischemia in rats

Neuroscience Letters

Volumn 436, Issue 1, 2008, Pages 40-43

  Tanaka, Yu ^a   Marumo, Toshiyuki ^a   Omura, Tomohiro ^a   Yoshida, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Biomarker; Cerebrospinal fluid; Focal cerebral ischemia; Rat; S100B

Indexed keywords

PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; NONHUMAN; PHOTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THROMBOEMBOLISM;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; MALE; NERVE GROWTH FACTORS; RATS; RATS, WISTAR; S100 PROTEINS; TIME;

EID: 41749088881     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.02.056     Document Type: Article

References (24)

1. Belayev L., Busto R., Zhao W., and Ginsberg M. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739 (1996) 88-96
2. Busnello J.V., Leke R., Oses J.P., Feier G., Bruch R., Quevedo J., Kapczinski F., Souza D.O., and Cruz Portela L.V. Acute and chronic electroconvulsive shock in rats: effects on peripheral markers of neuronal injury and glial activity. Life Sci. 78 (2006) 3013-3017
3. Diehl L.A., Silveira P.P., Leite M.C., Crema L.M., Portella A.K., Billodre M.N., Nunes E., Henriques T.P., Fidelix-da-Silva L.B., Heis M.D., Goncalves C.A., Quillfeldt J.A., and Dalmaz C. Long lasting sex-specific effects upon behavior and S100b levels after maternal separation and exposure to a model of post-traumatic stress disorder in rats. Brain Res. 1144 (2007) 107-116
4. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., Bohn M., Poser W., Ruther E., Kochen M., Gefeller O., Gleiter C., Wessel T.C., De Ryck M., Itri L., Prange H., Cerami A., Brines M., and Siren A.L. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8 (2002) 495-505
5. Elting J.W., Sulter G.A., Kaste M., Lees K.R., Diener H.C., Hommel M., Versavel M., Teelken A.W., and De Keyser J. AMPA antagonist ZK200775 in patients with acute ischemic stroke. Stroke 33 (2002) 2813-2818
6. Foerch C., du Mesnil de Rochemont R., Singer O.C., Neumann-Haefelin T., Buchkremer M., Zanella F.E., Steinmetz H., and Sitzer M. S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion. J. Neurol. Neurosurg, Psychiatry 74 (2003) 322-325
7. Foerch C., Otto B., Singer O.C., Neumann-Haefelin T., Yan B., Berkefeld J., Steinmetz H., and Sitzer M. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke 35 (2004) 2160-2164
8. Herrmann M., Vos P., Wunderlich M.T., de Bruijn C.H.M.M., and Lamers K.J.B. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S100B and glial fibrillary acidic protein. Stroke 31 (2000) 2670-2677
9. Kanner A.A., Marchi N., Fazio V., Mayberg M.R., Koltz M.T., Siomin V., Stevens G.H.J., Masaryk T., Ayumar B., Vogelbaum M.A., Barnett G.H., and Janigro D. Serum S100B: a noninvasive marker of blood-brain barrier function and brain lesion. Cancer 97 (2002) 2806-2813
10. Kapural M., Krizanac-Bengez L.J., Barnett G., Perl J., Masaryk T., Apollo D., Rasmussen P., Mayberg M.R., and Janigro D. Serum S100Beta as a possible marker of blood-brain barrier disruption. Brain Res. 940 (2002) 102-104
11. Kleindienst A., Harvey H.B., Rice A.C., Müller C., Hamm R.J., Gaab M.R., and Bullock M.R. Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat. J. Neurotrauma 21 (2004) 541-547
12. Kleindienst A., and Bullock R.M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J. Neurotrauma 23 (2006) 1185-1200
13. Matsui T., Mori T., Tateishi N., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Ikuta F., and Asano T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I. Enhanced astrocytic synthesis of S100B in the periinfarct area precedes delayed infarct expansion. J. Cereb. Blood Flow Metab. 22 (2002) 711-722
14. Matsuno H., Uematsu T., Umemura K., Takiguchi Y., Asai Y., Muranaka Y., and Nakashima M. A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this model. J. Pharmacol. Toxicol. Methods 29 (1993) 165-173
15. Park C.K., and Kang S.G. Effects of brain oedema in the measurement of ischemic brain damage in focal cerebral infarction. Acta Neurochir. Suppl. 76 (2000) 269-271
16. Petzold A., Keir G., Lim D., Smith M., and Thompson E.J. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res. Bull. 61 (2003) 281-285
17. Portela L.V., Tort A.B., Schaf D.V., Ribeiro L., Nora D.B., Walz R., Rotta L.N., Silva C.T., Busnello J.V., Kapczinski F., Goncalves C.A., and Souza D.O. The serum S100B concentration is age dependent. Clin. Chem. 48 (2002) 950-952
18. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-103030
19. Schäfer B.W., and Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 21 (1996) 134-140
20. Tanaka Y., Koizumi C., Marumo T., Omura T., and Yoshida S. Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model. Brain Res. 1137 (2007) 140-145
21. Tanaka Y., Marumo T., Omura T., and Yoshida S. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke. Brain Res. 1154 (2007) 194-199
22. Tanaka Y., Koizumi C., Marumo T., Omura T., and Yoshida S. Serum S100B is a useful surrogate marker for long-term outcomes in photochemically induced thrombotic stroke rat models. Life Sci. 81 2007 (2007) 657-663
23. Tateishi N., Mori T., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Matsui T., and Asano T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits. J. Cereb. Blood Flow Metab. 22 (2002) 723-734
24. Wunderlich M.T., Ebert A.D., Kratz T., Goertler M., Jost S., and Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 30 (1999) 1190-1195